Emmanuel Martínez-Ledesma
Emmanuel Martínez-Ledesma
Bioinformatics, Tecnológico de Monterrey, Escuela de Medicina
tec.mx üzerinde doğrulanmış e-posta adresine sahip
Başlık
Alıntı yapanlar
Alıntı yapanlar
Yıl
Inferring tumour purity and stromal and immune cell admixture from expression data
K Yoshihara, M Shahmoradgoli, E Martínez, R Vegesna, H Kim, ...
Nature communications 4 (1), 1-11, 2013
16592013
Tumor evolution of glioma-intrinsic gene expression subtypes associates with immunological changes in the microenvironment
Q Wang, B Hu, X Hu, H Kim, M Squatrito, L Scarpace, AC deCarvalho, ...
Cancer cell 32 (1), 42-56. e6, 2017
683*2017
SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis
R Aguirre-Gamboa, H Gomez-Rueda, E Martínez-Ledesma, ...
PloS one 8 (9), e74250, 2013
5232013
Integrated genomic and molecular characterization of cervical cancer
Cancer Genome Atlas Research Network
Nature 543 (7645), 378, 2017
4962017
Systematic analysis of telomere length and somatic alterations in 31 cancer types
FP Barthel, W Wei, M Tang, E Martinez-Ledesma, X Hu, SB Amin, ...
Nature genetics 49 (3), 349-357, 2017
2492017
TumorFusions: an integrative resource for cancer-associated transcript fusions
X Hu, Q Wang, M Tang, F Barthel, S Amin, K Yoshihara, FM Lang, ...
Nucleic acids research 46 (D1), D1144-D1149, 2018
1052018
Mutations in the SWI/SNF complex induce a targetable dependence on oxidative phosphorylation in lung cancer
YL Deribe, Y Sun, C Terranova, F Khan, J Martinez-Ledesma, J Gay, ...
Nature medicine 24 (7), 1047-1057, 2018
95*2018
Identification of a multi-cancer gene expression biomarker for cancer clinical outcomes using a network-based algorithm
E Martinez-Ledesma, RGW Verhaak, V Treviño
Scientific reports 5 (1), 1-14, 2015
682015
Multigene signature for predicting prognosis of patients with 1p19q co-deletion diffuse glioma
X Hu, E Martinez-Ledesma, S Zheng, H Kim, F Barthel, T Jiang, KR Hess, ...
Neuro-oncology 19 (6), 786-795, 2017
552017
Systematic epigenomic analysis reveals chromatin states associated with melanoma progression
P Fiziev, KC Akdemir, JP Miller, EZ Keung, NS Samant, S Sharma, ...
Cell reports 19 (4), 875-889, 2017
552017
Compact cancer biomarkers discovery using a swarm intelligence feature selection algorithm
E Martinez, MM Alvarez, V Trevino
Computational biology and chemistry 34 (4), 244-250, 2010
492010
Buparlisib in patients with recurrent glioblastoma harboring phosphatidylinositol 3-kinase pathway activation: an open-label, multicenter, multi-arm, phase II trial
PY Wen, M Touat, BM Alexander, IK Mellinghoff, S Ramkissoon, ...
Journal of clinical oncology 37 (9), 741, 2019
482019
Comparison of gene expression patterns across 12 tumor types identifies a cancer supercluster characterized by TP53 mutations and cell cycle defects
E Martínez, Y Kosuke, H Kim, GM Mills, V Treviño, V Roel GW
Oncogene 34 (21), 2732-2740, 2015
432015
Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions
R Tamura, K Yoshihara, T Saito, R Ishimura, JE Martínez-Ledesma, H Xin, ...
Oncogenesis 7 (1), 1-12, 2018
242018
Comparative molecular life history of spontaneous canine and human gliomas
SB Amin, KJ Anderson, CE Boudreau, E Martinez-Ledesma, E Kocakavuk, ...
Cancer cell 37 (2), 243-257. e7, 2020
18*2020
Targeting intercellular adhesion molecule-1 prolongs survival in mice bearing bevacizumab-resistant glioblastoma
Y Piao, V Henry, N Tiao, SY Park, J Martinez-Ledesma, JW Dong, ...
Oncotarget 8 (57), 96970, 2017
132017
Prognostic relevance of tumor purity and interaction with MGMT methylation in glioblastoma
ES Heuling, F Knab, J Radke, E Eskilsson, E Martinez-Ledesma, A Koch, ...
Molecular Cancer Research 15 (5), 532-540, 2017
13*2017
Integration and comparison of different genomic data for outcome prediction in cancer
H Gómez-Rueda, E Martínez-Ledesma, A Martínez-Torteya, ...
BioData mining 8 (1), 1-12, 2015
112015
Revealing protein networks and gene-drug connectivity in cancer from direct information
XL Jiang, E Martinez-Ledesma, F Morcos
Scientific reports 7 (1), 1-13, 2017
102017
EGFR amplification induces increased DNA damage response and renders selective sensitivity to Talazoparib (PARP inhibitor) in glioblastoma
S Wu, F Gao, S Zheng, C Zhang, E Martinez-Ledesma, R Ezhilarasan, ...
Clinical Cancer Research 26 (6), 1395-1407, 2020
9*2020
Sistem, işlemi şu anda gerçekleştiremiyor. Daha sonra yeniden deneyin.
Makaleler 1–20